Alogliptin (NESINA), a dipeptidyl peptidase IV (DPP-4) inhibitor, was approved by the FDA on January 25, 2013 to improve blood sugar control in adults with type 2 diabetes. This drug had been ...

A large study in older adults with type 2 diabetes finds that GLP-1 receptor agonists are associated with a modestly ...

Buying the right camera, lens, accessory or software to suit your photography is really important. Our product reviews offer independent views with hands-on opinion and honest verdicts aimed to ...

There is a low incidence rate of suicide-related adverse events among adults with diabetes or obesity being treated with GLP-1 RAs.